Exercise News and Research

Latest Exercise News and Research

Millennium, SGEN expand ADC collaboration

Seattle Genetics, Inc. announced today that Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, has paid an undisclosed fee to exercise an option to designate a second antigen target under the parties' existing antibody-drug conjugate (ADC) collaboration.

16 Mar 2011

Human growth, height, size: Reasons to be small

Almost everybody these days thinks that it is best to be tall, meaning much taller than the average traditional height of Asian populations, and even taller than the current average height of populations in high-income countries. It is also often believed – though people might be shy to admit this – that tall people are intrinsically superior to short people. The expressions 'look up to' and 'look down on' are significant.

15 Mar 2011

Illumina prices 0.25% Convertible Senior Notes due 2016

Illumina, Inc. today announced the pricing of $800 million principal amount of 0.25% Convertible Senior Notes due 2016 through offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

From Illumina, Inc. 15 Mar 2011

Experts to discuss on Alzheimer's disease prevention and treatment at ADI conference

From drug therapies to the right type of diet, the world's leading dementia experts will focus on the most effective methods for preventing and treating Alzheimer's disease and related dementias at the 26th Annual Conference of Alzheimer's Disease International.

15 Mar 2011

eToims launches new program with leading football franchise to improve athletic therapy

eToims Medical Technology has announced an innovative Sports Development Program with a leading UK football franchise to refine and improve athletic therapy and conditioning.

15 Mar 2011

ExonHit receives CE mark approval for AclarusDx to diagnose AD

ExonHit Therapeutics announces today CE marking of AclarusDx, its blood-based test intended to help in the diagnosis of Alzheimer's disease. This gives AclarusDx the status of In Vitro Diagnostic.

15 Mar 2011

Dog owners more physically active: proven many times over now

There is enough scientific evidence now to show that dogs can be powerful motivators to get people moving. Dog owners are more likely to take regular walks and new research has shown that dog walkers are more active overall than people who don’t have dogs. One of the studies showed that older people are more likely to take regular walks if the walking companion is canine rather than human.

14 Mar 2011

Ardea Biosciences fourth quarter net loss decreases to $0.6 million

Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and announced fourth quarter and full-year 2010 financial results.

11 Mar 2011

Centric Health 2010 revenue increases 70% to $62.5 million

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced financial results for the fourth quarter and year ended December 31, 2010.

11 Mar 2011

Neurogenesis plays a beneficial role in exercise-induced response to stress, sexual behavior and reproduction

Two studies published by an interdisciplinary team of Hong Kong researchers in the current special issue of Cell Transplantation (20:1), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , link the regrowth of key adult brain cells (neurogenesis) in two critical areas of the brain to both the benefits of exercise as a stress reducer and also to sexual behavior and reproductive issues.

11 Mar 2011

Study: Dog-walking can help increase physical activity in adults

Man's best friend may provide more than just faithful companionship: A new study led by a Michigan State University researcher shows people who owned and walked their dogs were 34 percent more likely to meet federal benchmarks on physical activity.

11 Mar 2011

FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD

Diabetes and high blood pressure are the two leading causes of chronic kidney disease, a health problem that is growing at an alarming rate in the United States. There are 26 million Americans who have CKD, and millions more are at increased risk and may not even know it.

11 Mar 2011

Gastric bypass patients tend to overuse alcohol

Patients who have had a gastric bypass operation take longer to process alcohol, potentially leading some of them to overindulge when drinking, according to the results of a new study in the February issue of the Journal of the American College of Surgeons.

11 Mar 2011

New MEAL study can stop or delay prostate cancer progression

The vegetables most boys wanted to avoid in childhood - such as kale and broccoli - just may be the answer to staving off prostate cancer growth in adulthood. A new clinical trial at UC San Diego Moores Cancer Center will evaluate whether or not a change in diet, reinforced with telephone counseling and exercise, can stop or delay the progression of prostate cancer.

11 Mar 2011

Seattle Children's Hospital inaugurates new dialysis unit

Today, timed with World Kidney Day, Seattle Children's Hospital announced the opening of its newly renovated dialysis unit. The unit will significantly improve patient comfort and safety compared to its predecessor facility, and includes an additional 630 square feet of space for a total of nearly 2,400 square feet.

11 Mar 2011

Dietitian offers nutrition tips to obtain maximum health benefits

March is National Nutrition Month, a campaign sponsored by the American Dietetic Association to promote nutrition education. This year's theme is Eat Right with Color.

11 Mar 2011

Sildenafil helps improve exercise performance in children with congenital heart disease

Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another possible use—helping children and young adults with congenital heart disease to better tolerate exercise.

11 Mar 2011

Cardiome total revenue for fiscal 2010 is $66.1 million

Cardiome Pharma Corp. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has initiated a Phase I clinical study with SAN-300, its anti-VLA-1 antibody.

10 Mar 2011

Exercise News and Research

Latest Exercise News and Research

Millennium, SGEN expand ADC collaboration

Human growth, height, size: Reasons to be small

Illumina prices 0.25% Convertible Senior Notes due 2016

Experts to discuss on Alzheimer's disease prevention and treatment at ADI conference

eToims launches new program with leading football franchise to improve athletic therapy

ExonHit receives CE mark approval for AclarusDx to diagnose AD

Dog owners more physically active: proven many times over now

Ardea Biosciences fourth quarter net loss decreases to $0.6 million

Centric Health 2010 revenue increases 70% to $62.5 million

Neurogenesis plays a beneficial role in exercise-induced response to stress, sexual behavior and reproduction

Study: Dog-walking can help increase physical activity in adults

FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD

Gastric bypass patients tend to overuse alcohol

New MEAL study can stop or delay prostate cancer progression

Seattle Children's Hospital inaugurates new dialysis unit

Dietitian offers nutrition tips to obtain maximum health benefits

Sildenafil helps improve exercise performance in children with congenital heart disease

Cardiome total revenue for fiscal 2010 is $66.1 million

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Exercise News and Research

Latest Exercise News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in